COX-2 expression during early lung squamous cell carcinomas oncogenesis Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005
Bevacizumab (Avastin®) aerosol therapy (AT) inhibits primary and metastatic tumor growth in a murine model with human non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Therapy increases poly(ADP-ribose), p53 expression, p53-Ser392 –P, and p53-Ser2 –P levels in recurrent squamous cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002
Mutant P53 expression in squamous cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002
LSC 2012 abstract – LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and preinvasive squamous cell carcinoma development Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012
Why is allograft formation in SCID mice slow in lung adenocarcinoma cell line with EGFR activating mutation? Source: Annual Congress 2010 - New insights in the pathology of lung cancer Year: 2010
Angiogenic squamous dysplasia: highly associated with squamous cell lung carcinoma Source: Annual Congress 2006 - Biological features, lung function and treatment of lung cancer Year: 2006
Distinct angiogenic and non-angiogenic growth patterns of lung metastases (LM) from renal cell carcinoma (RCC) Source: Eur Respir J 2003; 22: Suppl. 45, 362s Year: 2003
Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement Source: Eur Respir J 2007; 30: 21-26 Year: 2007
Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018
Prognostic value of three-microRNA expression profile in early stage squamous cell lung cancer (SqCLC) Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010
Epidermal growth factor receptor (EGFR) expression in non-small cell lung carcinoma (NSCLC) and survival Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Bilateral squamous cell carcinoma Source: Annual Congress 2008 - Various thoracic tumours and interesting cases Year: 2008
Differences in growth signaling pathway activation in small cell and non-small cell carcinomas of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 326s Year: 2006
Squamous cell carcinoma Source: International Congress 2015 – Lung cancer pathology Year: 2015
D2-40 as a diagnostic marker for pulmonary squamous cell carcinoma Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
Differentiation between squamous cell carcinoma (SCC) and adenocarcinoma (AC): Expression of immunohistochemical (IHC) markers in a tissue microarray (TMA) of >1000 NSCLC Source: Annual Congress 2011 - Molecular pathology and functional genomics of lung disease Year: 2011
Targeting gene of insulin-like growth factor type I (IGF-I) on in vitro model of A549 cell line with triple-helix approach. Perspectives of gene therapy in non-small cell lung (NSCLC) cancer Source: Eur Respir J 2006; 28: Suppl. 50, 387s Year: 2006
Expression of vascular endothelial growth factor (VEGF) and association with lymphangiogenesis in non small cell (NSCLC) and small cell lung carcinomas (SCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 386s Year: 2006